Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage

Molecular and Cellular Biology

Volumn 24, Issue 23, 2004, Pages 10328-10339

  Tulasne, David ^a   Deheuninck, Julien ^a   Lourenço, Filipe Calheiros ^b   Lamballe, Fabienne ^c   Ji, Zongling ^a   Leroy, Catherine ^a   Puchois, Emilie ^a   Moumen, Anice ^c   Maina, Flavio ^c   Mehlen, Patrick ^b   Fafeur, Véronique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; PROTEIN P40; SCATTER FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CELL; CELL SURVIVAL; CONTROLLED STUDY; DOG; EMBRYO; EMBRYO CELL; ENZYME ACTIVITY; EPITHELIUM CELL; IN VITRO STUDY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; ASPARTIC ACID; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEPATOCYTES; IN SITU NICK-END LABELING; LIGANDS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; NEURONS; PLASMIDS; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MET; RECOMBINANT PROTEINS; TRANSFECTION; TYROSINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 8644229302     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.23.10328-10339.2004     Document Type: Article

References (42)

1. Arakaki, N., J. A. Kazi, T. Kazihara, T. Ohnishi, and Y. Daikuhara. 1998. Hepatocyte growth factor/scatter factor activates the apoptosis signaling pathway by increasing caspase-3 activity in sarcoma 180 cells. Biochem. Biophys. Res. Commun. 245:211-215.
2. Bae, S. S., J. H. Choi, Y. S. Oh, D. K. Perry, S. H. Ryu, and P. G. Suh. 2001. Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Lett. 491:16-20.
3. Birchmeier, C., W. Birchmeier, E. Gherardi, and G. F. Vande Woude. 2003. Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4:915-925.
4. Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768-771.
5. Bordeaux, M. C., C. Forcet, L. Granger, V. Corset, C. Bidaud, M. Billaud, D. E. Bredesen, P. Edery, and P. Mehlen. 2000. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J. 19:4056-4063.
6. Crepaldi, T., M. Prat, S. Giordano, E. Medico, and P. M. Comoglio. 1994. Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum. J. Biol. Chem. 269:1750-1755.
7. Di Renzo, M. F., M. Olivero, T. Martone, A. Maffe, P. Maggiora, A. D. Stefani, G. Valente, S. Giordano, G. Cortesina, and P. M. Comoglio. 2000. Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 19:1547-1555.
8. Furge, K. A., Y. W. Zhang, and G. F. Vande Woude. 2000. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 19:5582-5589.
9. Gandino, L., P. Longati, E. Medico, M. Prat, and P. M. Comoglio. 1994. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. J. Biol. Chem. 269:1815-1820.
10. Jeffers, M., G. A. Taylor, K. M. Weidner, S. Omura, and G. F. Vande-Woude. 1997. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 17:799-808.
11. Kosai, K., K. Matsumoto, S. Nagata, Y. Tsujimoto, and T. Nakamura. 1998. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 244:683-690.
12. Lee, C. C., and K. M. Yamada. 1995. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. Deletion alters cellular tyrosine phosphorylation pattern and facilitates binding of phosphatidylinositol-3-OH kinase to the hepatocyte growth factor receptor. J. Biol. Chem. 270:507-510.
13. Lee, Z. H., S. E. Lee, K. Kwack, W. Yeo, T. H. Lee, S. S. Bae, P. G. Suh, and H. H. Kim. 2001. Caspase-mediated cleavage of TRAF3 in FasL-stimulated Jurkat-T cells. J. Leukoc. Biol. 69:490-496.
14. Liu, Y., A. M. Sun, and L. D. Dworkin. 1998. Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death. Biochem. Biophys. Res. Commun. 246:821-826.
15. Llambi, F., F. Causeret, E. Bloch-Gallego, and P. Mehlen. 2001. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J. 20:2715-2722.
16. Lorenzato, A., M. Olivero, S. Patane, E. Rosso, A. Oliaro, P. M. Comoglio, and M. F. Di Renzo. 2002. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. Cancer Res. 62:7025-7030.
17. Maina, F., M. C. Hilton, C. Ponzetto, A. M. Davies, and R. Klein. 1997. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 11:3341-3350.
18. Maina, F., G. Pante, F. Helmbacher, R. Andres, A. Porthin, A. M. Davies, C. Ponzetto, and R. Klein. 2001. Coupling Met to specific pathways results in distinct developmental outcomes. Mol. Cell 7:1293-1306.
19. Mehlen, P., S. Rabizadeh, S. J. Snipas, N. Assa-Munt, G. S. Salvesen, and D. E. Bredesen. 1998. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801-804.
20. Nakamura, T. 1991. Structure and function of hepatocyte growth factor. Prog. Growth Factor Res. 3:67-85.
21. Naldini, L., K. M. Weidner, E. Vigna, G. K. Gaudino, A. Bardelli, C. Ponzetto, R. P. Narsimhan, G. Hartmann, R. Zarnegar, G. Michalopoulos, W. Birchmeier, and P. M. Comoglio. 1991. Scatter factor and hepatocyte growth factor are undistinguishable ligands for the MET receptor. EMBO J. 10:2867-2878.
22. Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
23. Paumelle, R., D. Tulasne, Z. Kherrouche, S. Plaza, C. Leroy, S. Reveneau, B. Vandenbunder, and V. Fafeur. 2002. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21:2309-2319.
24. Peschard, P., T. M. Fournier, L. Lamorte, M. A. Naujokas, H. Band, W. Y. Langdon, and M. Park. 2001. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 8:995-1004.
25. Petrelli, A., G. F. Gilestro, S. Lanzardo, P. M. Comoglio, N. Migone, and S. Giordano. 2002. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416:187-190.
26. Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, P. dalla Zonca, S. Giordano, A. Graaziani, G. Panayotou, and P. M. Comoglio. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261-271.
27. Sakata, H., H. Takayama, R. Sharp, J. S. Rubin, G. Merlino, and W. J. LaRochelle. 1996. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ. 7:1513-1523.
28. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeier. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-702.
29. Schmidt, L., F. M. Duh, F. Chen, T. Kishida, G. Glenn, P. Choyke, S. W. Scherer, Z. Zhuang, I. Lubensky, M. Dean, R. Allikmets, A. Chidambaram, U. R. Bergerheim, J. T. Feltis, C. Casadevall, A. Zamarron, M. Bernues, S. Richard, C. J. Lips, M. M. Walther, L. C. Tsui, L. Geil, M. L. Orcutt, T. Stackhouse, B. Zbar, et al. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:68-73.
30. Stoker, M., and M. Ferryman. 1985. An epithelial scatter factor released by embryo fibroblasts. J. Cell Sci. 77:209-223.
31. Taher, T. E., E. P. Tjin, E. A. Beuling, J. Borst, M. Spaargaren, and S. T. Pals. 2002. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J. Immunol. 169:3793-3800.
32. Tikhomirov, O., and G. Carpenter. 2001. Caspase-dependent cleavage of ErbB-2 by geldanamycin and staurosporin. J. Biol. Chem. 276:33675-33680.
33. Tulasne, D., R. Paumelle, K. M. Weidner, B. Vandenbunder, and V. Fafeur. 1999. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol. Biol. Cell 10:551-565.
34. Uehara, Y., O. Minowa, C. Mori, K. Shlota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702-705.
35. Vigna, E., D. Gramaglia, P. Longati, A. Bardelli, and P. M. Comoglio. 1999. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET. Oncogene 18:4275-4281.
36. Villa-Moruzzi, E., F. Puntoni, A. Bardelli, E. Vigna, S. De Rosa, and P. M. Comoglio. 1998. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met. Biochem. J. 336:235-239.
37. Wang, X., M. C. DeFrances, Y. Dai, P. Pediaditakis, C. Johnson, A. Bell, G. K. Michalopoulos, and R. Zarnegar. 2002. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol. Cell 9:411-421.
38. Weidner, K. M., S. Dicesare, M. Sachs, V. Brinkmann, J. Behrens, and W. Birchmeier. 1996. Interaction between gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173-176.
39. Weidner, K. M., G. Hartmann, L. Naldini, P. M. Comoglio, M. Sachs, C. Fonatsch, H. Rieder, and W. Birchmeier. 1993. Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS 65:311-328.
40. Weidner, K. M., M. Sachs, and W. Birchmeier. 1995. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc. Natl. Acad. Sci. USA 92:2597-2601.
41. Widmann, C., P. Gerwins, N. L. Johnson, M. B. Jarpe, and G. L. Johnson. 1998. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18:2416-2429.
42. Yo, Y., R. Morishita, S. Nakamura, N. Tomita, K. Yamamoto, A. Moriguchi, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara. 1998. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int. 54:1128-1138.